Literature DB >> 7000153

Bone marrow transplantation in Fanconi anaemia.

E Gluckman, A Devergie, G Schaison, A Bussel, R Berger, J Sohier, J Bernard.   

Abstract

Five patients with Fanconi anaemia have been treated by bone marrow transplantation from HLA identical donors. Only one patient survived for more than 3 years. She is now perfectly healthy with complete haematological reconstitution with chimaerism and disparition of chromosomal abnormalities. In contrast, four patients died of acute severe GVHD soon after grafting. In addition, all had signs of severe cyclophosphamide toxicity. This evolution could be explained by a special sensitivity of FA cells to alkylating agents and may indicate the need to modify the conditioning regimen in FA patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000153     DOI: 10.1111/j.1365-2141.1980.tb07178.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.

Authors:  Robert B Gerbing; Todd A Alonzo; Lillian Sung; Alan S Gamis; Soheil Meshinchi; Sharon E Plon; Alison A Bertuch; Maria M Gramatges
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

2.  Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?

Authors:  Parinda A Mehta; Chie Emoto; Tsuyoshi Fukuda; Brian Seyboth; Ashley Teusink-Cross; Stella M Davies; Jamie Wilhelm; Kirsten Fuller; Alexander A Vinks; Farid Boulad
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-18       Impact factor: 5.742

Review 3.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

4.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

Review 5.  Cytogenomics of cancers: from chromosome to sequence.

Authors:  Alain Bernheim
Journal:  Mol Oncol       Date:  2010-06-11       Impact factor: 6.603

6.  Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.

Authors:  Siobán B Keel; Angela Scott; Marilyn Sanchez-Bonilla; Phoenix A Ho; Suleyman Gulsuner; Colin C Pritchard; Janis L Abkowitz; Mary-Claire King; Tom Walsh; Akiko Shimamura
Journal:  Haematologica       Date:  2016-07-14       Impact factor: 9.941

7.  Marrow transplantation for pancytopenia in dyskeratosis congenita.

Authors:  H K Mahmoud; U W Schaefer; C G Schmidt; R Becher; G F Götz; H J Richter
Journal:  Blut       Date:  1985-07

8.  Treatment of the hematological manifestations of dyskeratosis congenita.

Authors:  C Putterman; R Safadi; J Zlotogora; R Banura; A Eldor
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

9.  In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

Authors:  Miharu Yabe; Hiromasa Yabe; Satoshi Hamanoue; Hiroyasu Inoue; Masae Matsumoto; Takashi Koike; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Satoshi Arakawa; Toshio Ohshima; Atsuko Masukawa; Hayato Miyachi; Takayuki Yamashita; Shunichi Katob
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

10.  HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.

Authors:  Carmem M Bonfim; Carlos R de Medeiros; Marco A Bitencourt; José Zanis-Neto; Vaneuza A M Funke; Daniela C Setubal; Jefferson Ruiz; Jean E Sanders; Mary E D Flowers; Hans-Peter Kiem; Rainer Storb; Ricardo Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2007-10-18       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.